Alternative splicing of BRAF transcripts and characterization of C-terminally truncated B-Raf isoforms in colorectal cancer

International Journal of Cancer

Volumn 133, Issue 3, 2013, Pages 590-596

  Hirschi, Benjamin ^a   Kolligs, Frank T ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

alternative splicing; B Raf; BRAF; isoform

Indexed keywords

B RAF KINASE; GLUTAMIC ACID; ISOENZYME; MESSENGER RNA; PROTEIN VARIANT; VALINE;

ALTERNATIVE RNA SPLICING; ARTICLE; BRAF GENE; CANCER CELL; CARBOXY TERMINAL SEQUENCE; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ACTIVATION; ENZYME ACTIVITY; EXON; GENE EXPRESSION; GENE FREQUENCY; GENE PRODUCT; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MOLECULAR CLONING; PRIORITY JOURNAL; PROTO ONCOGENE;

ALTERNATIVE SPLICING; BASE SEQUENCE; CELL LINE, TUMOR; CLONING, MOLECULAR; COLORECTAL NEOPLASMS; GENETIC VARIATION; HUMANS; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS B-RAF; RNA SPLICING; SEQUENCE ANALYSIS, DNA;

EID: 84878017307     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28061     Document Type: Article

References (30)

1. Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature 2002; 417: 949-54.
2. Oshima M, Sithanandam G, Rapp UR, et al. The phosphorylation and activation of B-raf in PC12 cells stimulated by nerve growth factor. J Biol Chem 1991; 266: 23753-60.
3. Eychène A, Barnier JV, Dézélée P, et al. Quail neuroretina c-Rmil(B-raf) proto-oncogene cDNAs encode two proteins of 93.5 and 95 kDa resulting from alternative splicing. Oncogene 1992; 7: 1315-23.
4. Eychène A, Dusanter-Fourt I, Barnier JV, et al. Expression and activation of B-Raf kinase isoforms in human and murine leukemia cell lines. Oncogene 1995; 10: 1159-65.
5. Barnier JV, Papin C, Eychène A, et al. The mouse B-raf gene encodes multiple protein isoforms with tissue-specific expression. J Biol Chem 1995; 270: 23381-9.
6. Papin C, Denouel-Galy A, Laugier D, et al. Modulation of kinase activity and oncogenic properties by alternative splicing reveals a novel regulatory mechanism for B-Raf. J Biol Chem 1998; 273: 24939-47.
7. Hmitou I, Druillennec S, Valluet A, et al. Differential regulation of B-raf isoforms by phosphorylation and autoinhibitory mechanisms. Mol Cell Biol 2007; 27: 31-43.
8. Valluet A, Hmitou I, Davis S, et al. B-raf alternative splicing is dispensable for development but required for learning and memory associated with the hippocampus in the adult mouse. PLoS One 2010; 5: e15272.
9. Seth R, Crook S, Ibrahem S, et al. Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signaling pathway in advanced colorectal cancer. Gut 2009; 58: 1234-41.
10. Poulikakos PI, Persaud Y, Janakiraman M, et al. RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E). Nature 2011; 480: 387-90.
11. Jass JR,. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 2007; 50: 113-30.
12. Baehs S, Herbst A, Thieme SE, et al. Dickkopf-4 is frequently down-regulated and inhibits growth of colorectal cancer cells. Cancer Lett 2009; 276: 152-9.
13. Kleivi K, Teixeira MR, Eknaes M, et al. Genome signatures of colon carcinoma cell lines. Cancer Genet Cytogenet. 2004; 155: 119-31.
14. Lewis BP, Green RE, Brenner SE,. Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proc Natl Acad Sci USA 2003; 100: 189-92.
15. Calipel A, Lefevre G, Pouponnot C, et al. Mutation of B-Raf in human choroidal melanoma cells mediates cell proliferation and transformation through the MEK/ERK pathway. J Biol Chem 2003; 278: 42409-18.
16. Wan PT, Garnett MJ, Roe SM, et al. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell 2004; 116: 855-67.
17. Heidorn SJ, Milagre C, Whittaker S, et al. Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF. Cell 2010; 140: 209-21.
18. Baitei EY, Zou M, Al-Mohanna F, et al. Aberrant BRAF splicing as an alternative mechanism for oncogenic B-Raf activation in thyroid carcinoma. J Pathol 2009; 217: 707-15.
19. Poulikakos PI, Zhang C, Bollag G, et al. RAF inhibitors transactivate RAF dimers and ERK signaling in cells with wild-type BRAF. Nature 2010; 464: 427-30.
20. Johnson JM, Castle J, Garrett-Engele P, et al. Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 2003; 302: 2141-4.
21. Wollerton MC, Gooding C, Wagner EJ, et al. Autoregulation of polypyrimidine tract binding protein by alternative splicing leading to nonsense-mediated decay. Mol Cell 2004; 13: 91-100.
22. Boise LH, González-García M, Postema CE, et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993; 74: 597-608.
23. Heaney ML, Golde DW,. Soluble cytokine receptors. Blood 1996; 87: 847-57.
24. Stalder L, Mühlemann O,. The meaning of nonsense. Trends Cell Biol 2008; 18: 315-21.
25. Pan Q, Saltzman AL, Kim YK, et al. Quantitative microarray profiling provides evidence against widespread coupling of alternative splicing with nonsense-mediated mRNA decay to control gene expression. Genes Dev 2006; 20: 153-8.
26. Colotta F, Re F, Muzio M, et al. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 1993; 261: 472-5.
27. Yonekura H, Yamamoto Y, Sakurai S, et al. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem J 2003; 370 (Part 3): 1097-1109.
28. Kalea AZ, Reiniger N, Yang H, et al. Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene. FASEB J 2009; 23: 1766-1774.
29. Yokoyama T, Takano K, Yoshida A, et al. DA-Raf1, a competent intrinsic dominant-negative antagonist of the Ras-ERK pathway, is required for myogenic differentiation. J Cell Biol 2007; 177: 781-793.
30. Rauch J, Moran-Jones K, Albrecht V, et al. c-Myc regulates RNA splicing of the A-Raf kinase and its activation of the ERK pathway. Cancer Res 2011; 71: 4664-4674.